SCHEMBL29985642

SCHEMBL29985642

Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@@H](O)[C@@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 3/20 0.92
HSD17B10 Q99714 3/20 0.92
ALOX15 P16050 2/20 0.92
CYP1A2 P05177 1/20 0.92
MMP2 P08253 4/20 0.91
MMP9 P14780 4/20 0.91
PRKD3 O94806 3/20 0.91
PRKCG P05129 3/20 0.91
PRKCB P05771 3/20 0.91
PRKCA P17252 3/20 0.91
PRKCH P24723 3/20 0.91
PRKCI P41743 3/20 0.91
PRKCE Q02156 3/20 0.91
PRKCQ Q04759 3/20 0.91
PRKCZ Q05513 3/20 0.91
PRKCD Q05655 3/20 0.91
PRKD1 Q15139 3/20 0.91
PTGS1 P23219 2/20 0.87
PDE4D Q08499 1/20 0.63
BACE1 P56817 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19424170 1.00 SNCA (0.92) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL14413656 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL18685718 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL677697 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL14626386 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL23251016 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL14339427 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL22043665 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL20661403 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2
Procyanidin B2 SCHEMBL15142352 0.96 SNCA (1.00) SNCAHSD17B10ALOX15CYP1A2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240182435-A1 CHEMICAL SYNTHESIS METHOD OF PRODELPHINIDIN B9 GALLATE ZHEJIANG UNIVERSITY (CN) 2024-06-06 US claimed
WO-2022241749-A1 METHOD FOR CHEMICAL SYNTHESIS OF PRODELPHINIDIN B9 GALLATE 浙江大学 2022-11-24 WO claimed
EP-3286294-B1 METHOD AND DEVICE FOR STABILIZING POLYPHENOL-CONTAINING LIQUIDS KHS GMBH (DE) 2022-10-05 EP claimed
WO-2025132483-A1 METHOD FOR MANUFACTURING A COMPOSITION INVIVO GROUP (FR) 2025-06-26 WO disclosed
US-20240182435-A1 CHEMICAL SYNTHESIS METHOD OF PRODELPHINIDIN B9 GALLATE ZHEJIANG UNIVERSITY (CN) 2024-06-06 US disclosed
US-20230357336-A1 PHOSVITIN COMPOSITIONS AND METHODS OF MAKINGAND USING BET BIOSCIENCE EXTRACTION TECHNOLOGIES INC. (CA) 2023-11-09 US disclosed
EP-4178622-A1 PHOSVITIN COMPOSITIONS AND METHODS OF MAKING AND USING BET Bioscience Extraction Technologies Inc. (CA) 2023-05-17 EP disclosed
CN-115612114-A Copolymer membrane and enzymatic self-assembly synthesis method and application thereof 中国科学院天津工业生物技术研究所 2023-01-17 CN disclosed
CN-115612699-A Copolymer membrane and enzymatic self-assembly synthesis method and application thereof at gas-liquid interface 中国科学院天津工业生物技术研究所 2023-01-17 CN disclosed
CN-115612403-A Self-assembly strong-adhesion copolymer film, film coating method and application 中国科学院天津工业生物技术研究所 2023-01-17 CN disclosed
WO-2022241749-A1 METHOD FOR CHEMICAL SYNTHESIS OF PRODELPHINIDIN B9 GALLATE 浙江大学 2022-11-24 WO disclosed
EP-3286294-B1 METHOD AND DEVICE FOR STABILIZING POLYPHENOL-CONTAINING LIQUIDS KHS GMBH (DE) 2022-10-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182435-A1 CHEMICAL SYNTHESIS METHOD OF PRODELPHINIDIN B9 GALLATE C9, GAPVD1, GCLC SNCA 332/4885HSD17B10 2134/4885ALOX15 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.